MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

GoodRx Holdings Inc

Geschlossen

BrancheGesundheitswesen

4.74 -6.51

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.68

Max

4.86

Schlüsselkennzahlen

By Trading Economics

Einkommen

4.3M

11M

Verkäufe

4.4M

203M

KGV

Branchendurchschnitt

71.143

40.527

EPS

0.09

Gewinnspanne

5.445

Angestellte

738

EBITDA

-15M

27M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+34.61% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

7. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

216M

1.8B

Vorheriger Eröffnungskurs

11.25

Vorheriger Schlusskurs

4.74

Nachrichtenstimmung

By Acuity

50%

50%

115 / 375 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

GoodRx Holdings Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Juli 2025, 04:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

4. Juli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. Juli 2025, 15:57 UTC

Market Talk

Base Metal Prices Fall in Thin, Risk-off Trading -- Market Talk

4. Juli 2025, 15:49 UTC

Market Talk

Gold Futures Set to End Week Flat After Mixed Jobs Report -- Market Talk

4. Juli 2025, 15:49 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: Deal Will Have a Negative Impact of Approximately 30 Basis Points on the Fully-Loaded CET1 Ratio

4. Juli 2025, 15:49 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: Transaction Is Consistent With Targets in Terms of Return of Investment, Return on Tangible Equity

4. Juli 2025, 15:49 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole Received All Required Authorizations

4. Juli 2025, 15:48 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: CACEIS and Santander Are Maintaining Their Long-Term Partnership

4. Juli 2025, 15:47 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: Agreement Was Announced on Dec. 19

4. Juli 2025, 15:47 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole Now Controls 100% of the Share Capital of CACEIS

4. Juli 2025, 15:46 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole Completes Acquisition of Santander's 30.5% Stake in CACEIS

4. Juli 2025, 14:30 UTC

Akquisitionen, Fusionen, Übernahmen

Rocky Shore Closes Hemlo Area Claims Sale to Barrick Mining Unit for C$975,000 Cash

4. Juli 2025, 13:53 UTC

Market Talk

Polish Zloty Faces Hit From Prospect of Further Rate Cuts -- Market Talk

4. Juli 2025, 13:41 UTC

Market Talk

Japanese Yen Could Receive Boost From Increased Rate-Hike Bets -- Market Talk

4. Juli 2025, 13:41 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

4. Juli 2025, 13:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. Juli 2025, 12:37 UTC

Market Talk

Fund Manager Roundup: U.S. Treasurys in Focus Amid Rising Debt

4. Juli 2025, 12:37 UTC

Market Talk

Fund Manager Roundup: U.S. Treasurys in Focus -2-

4. Juli 2025, 12:30 UTC

Market Talk

Fund Manager Roundup: U.S. Tariff Deadline Key for Dollar Outlook, U.K. Fiscal Risks In Focus for Pound

4. Juli 2025, 12:15 UTC

Market Talk

Targeted Tariffs Would Likely Support Dollar -- Market Talk

4. Juli 2025, 12:13 UTC

Market Talk

Further Pause in Tariffs Would Have Unclear Impact on Dollar -- Market Talk

4. Juli 2025, 12:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Peer-Vergleich

Kursveränderung

GoodRx Holdings Inc Prognose

Kursziel

By TipRanks

34.61% Vorteil

12-Monats-Prognose

Durchschnitt 6.34 USD  34.61%

Hoch 9 USD

Tief 4 USD

Basierend auf 12 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für GoodRx Holdings Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

12 ratings

7

Buy

4

Halten

1

Sell

Technischer Score

By Trading Central

3.675 / 4.65Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Weak Bearish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

115 / 375 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Durchschnitt

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über GoodRx Holdings Inc

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.